RECRUITINGOBSERVATIONAL
Community Screening Study of Diabetic Retinopathy in Tianjin in 2024
About This Trial
Through this study, the investigators hope to understand the prevalence and influencing factors of diabetic retinopathy in Tianjin, improve the ability of complication detection and intervention in diabetic patients in primary medical and health institutions, and build a diabetes prevention and treatment network. The investigators should adhere to the policy of prevention first, combined with prevention and control, and explore a diabetes' prevention and control model suitable for our city. Extensive publicity and education should be carried out to improve the awareness of self-management ，improve the screening rate of diabetic retinopathy, and reduce the blindness rate.
Who May Be Eligible (Plain English)
Who May Qualify:
\- 1: Clear awareness, barrier-free communication
2: diabetes
Who Should NOT Join This Trial:
- 1: Have left the registered home address
2: In the last 6 months, you have not lived in your place of residence
3: Have a serious mental illness
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
\- 1: Clear awareness, barrier-free communication
2: diabetes
Exclusion Criteria:
* 1: Have left the registered home address
2: In the last 6 months, you have not lived in your place of residence
3: Have a serious mental illness
Locations (1)
Tianjin Medical University Eye Hospital
Tianjin, Tianjin Municipality, China